SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-025671
Filing Date
2023-02-06
Accepted
2023-02-06 16:43:26
Documents
5
Effectiveness Date
2023-02-06

Document Format Files

Seq Description Document Type Size
1 S-8 d449765ds8.htm S-8 40760
2 EX-5.1 d449765dex51.htm EX-5.1 6319
3 EX-23.1 d449765dex231.htm EX-23.1 1907
4 EX-FILING FEES d449765dexfilingfees.htm EX-FILING FEES 15666
5 GRAPHIC g449765g80z17.jpg GRAPHIC 3865
  Complete submission text file 0001193125-23-025671.txt   71226
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269600 | Film No.: 23591240
SIC: 2834 Pharmaceutical Preparations